Keynote, Invited and Guest Speakers

The BAD Conference & Events Committee is extremely grateful to the contribution of the Keynote, Invited and Guest lecturers that attend the BAD Annual Meeting speaking in the Plenary and concurrent sessions. Some are familiar BAD Members, whilst others are from outside both the association and the specialty. All offer an invaluable educational benefit to our members and we are very thankful.

Details will appear here shortly on the Keynote and Invited Lecturers for the 2021 Annual Meeting.

Celia Moss is a Consultant Dermatologist at Birmingham Children’s Hospital and Honorary Professor of Paediatric Dermatology at the University of Birmingham. She trained in Medicine at Oxford University and University College Hospital, London, and in Dermatology in Newcastle-upon-Tyne. Previous national appointments include Chair of the British Society for Paediatric Dermatology, Chair of the UK NHS Clinical Reference Group for Specialised Dermatology, Convenor for Dermatology at the Royal College of Paediatrics and Child Health and Council Member of the Royal Society of Medicine Dermatology Section. She is a member of the advisory boards of several dermatology journals and patient support groups. She lectures, advises and publishes widely on genetic and paediatric dermatology, and has contributed chapters to the major UK and US textbooks. She was awarded the Sir Archibald Gray Medal and an OBE in 2016. Now semi-retired, she and her husband travel whenever possible, supporting colleagues overseas, particularly in India.

Professor Gail Davey is a medical epidemiologist specialising in skin-related Neglected Tropical Diseases. Following training in epidemiology at Master and doctoral level at the London School of Hygiene & Tropical Medicine, Gail moved to Ethiopia to work with national colleagues in the School of Public Health, Addis Ababa University. Over nine years in Addis Ababa, she supervised more than 40 Master theses and helped develop a PhD Public Health program. Initially, Gail took forward research into asthma aetiology, but in 2005, she initiated a multidisciplinary program of research into podoconiosis (non-filarial endemic elephantiasis). The programme has covered distribution, aetiology (genetic, mineralogical and biochemical), consequences (economic, social and ethical), management of disease (diagnosis, clinical staging, treatment and health systems). To date, over 80 research articles and 10 reviews and book chapters have arisen from this program. In 2010, Gail returned to the UK on a Wellcome Trust University Award to expand podoconiosis research within Ethiopia and into other endemic countries.

In parallel with this research, Gail has worked to raise the local and international profile of podoconiosis, advocating for inclusion in the WHO list of Neglected Tropical Diseases (NTDs); ensuring podoconiosis was among the eight NTDs prioritised by the Ethiopian Federal Ministry of Health; guiding the foundation of the Ethiopian National Podoconiosis Action Network (NaPAN); and establishing Footwork, the International Podoconiosis Initiative. This is summarized in a Profile published in the Lancet in March 2012.

Emma Guttman-Yassky, MD, PhD is the system chair of the department of dermatology, and the Sol and Clara Kest Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City. She is the Director of the center for excellence in eczema and the occupational dermatitis clinic and director of the laboratory for inflammatory skin diseases. She earned her M.D. degree from Sackler School of Medicine at the Tel-Aviv University, and a Ph.D. degree from the Bar-Ilan University, Israel. After obtaining her Israeli Board certification in dermatology at Rambam Medical Center/Technion, Israel, Dr. Guttman moved to the U.S. to pursue a two-year postdoctoral fellowship at The Rockefeller University in the Laboratory for Investigative Dermatology. Upon completion of her fellowship, she became board-certified by the American Board of dermatology after a second dermatology residency training at the Weill-Cornell Medical College, in NY. Dr. Guttman’s major clinical and research focus areas are atopic dermatitis (AD)/eczema and alopecia areata. Her research made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis (AD)/eczema in adults and children with atopic dermatitis, enriching the understanding of the pathophysiology of this common disorder, opening the door and accelerating testing of novel immune, pathway-specific drugs in this disease. She is now testing (both clinically and mechanistically) multiple targeted therapeutics for atopic dermatitis that target Th2, Th22, and Th17/IL-23 axis. Recently Dr. Guttman also extended her research interest to hair loss disorders such as alopecia areata and scarring hair loss disorders, chronic hand eczema, keloids, ichtyosis, and other skin diseases, in which her findings are also translated to novel therapeutic targets.

Dr. Guttman is considered one of the world’s leading experts in inflammatory skin diseases. Her achievements have been repeatedly highlighted by the media including the New York Times, ABC news, CBS news, Daily news, Reuters, wall street journal, NY1, and others.

Dr. Guttman divides her time between a busy clinic, where she sees patients from all over the US and the world, that are coming to seek her advise in treating inflammatory skin diseases, and her growing laboratory that focuses on research on the mechanisms underlying inflammatory skin diseases, leading to novel treatments for these patients.

She co-founded the international eczema council (IEC), for which she functions as president since early 2018. Dr. Guttman received many national and international awards, including the American Academy of Allergy and Clinical Immunology (AAAAI) Award for Scientific Innovation, American Academy of Dermatology Young Investigator awards, and others. She was elected as a member to the American Society for Clinical Investigation (ASCI), as well as the American Dermatological Society (ADA. Dr. Gutman is often invited as a keynote speaker to international and national meetings, and authored ~240 peer-reviewed publications. Dr. Guttman is also the co-organizer of the inflammatory skin disease summit, that is considered one of the most successful meetings in dermatology.

Markus Magerl graduated with a medical degree from Humboldt University Berlin in 2000. In 2003 he completed his doctoral thesis examining proliferation and apoptosis in murine hair follicle morphogenesis and anagen. Afterwards his interests focused on mast cells, urticaria and angioedema. He is currently a Professor of Dermatology and Senior Physician at Charité – Universitätsmedizin Berlin, Germany.

Professor Magerl is a member of the Deutsche Dermatologische Gesellschaft (German Society of Dermatologists), the European Academy of Allergology and Clinical Immunology and the Urticaria Network e.V. He also serves as a reviewer for a number of journals in the field of dermatology and allergy.

Rodney Sinclair is the Professor of Dermatology at the University of Melbourne and the Director of the Sinclair Dermatology Institute for Research, Education and Clinical Trials.

He is co-founder and Past-President of the Australasian Society for Dermatology Research and the Australasian Hair and Wool Research Society and also Past–President of the Skin and Cancer Foundation of Victoria.

Rod Sinclair was born in Melbourne graduated from the University of Melbourne in Medicine in 1987. He was a locum dermatology registrar at the Slade Hospital in Oxford in1991-92 and locum senior registrar at the Churchill Hospital in Oxford from 1993-1994. He completed his Fellowship of the Australasian College of Dermatologists in 1995 and Doctorate of Medicine in 2004.

Prof Sinclair is Secretary General for the International Congress of Dermatology in Melbourne in November 2021 and will also convene the World Congress of Hair Research in Melbourne in April 2022.

He has supervised over 15 post-graduate students and established the PhD/FACD program in Australia to foster clinician scientists. Prof Sinclair is an honorary member of the American Dermatology Association, an overseas member of the British Association of Dermatologists and the American Academy of Dermatology. He is a Board member of the International Society of Dermatology and the International Academy of Cosmetic Dermatology.

Janellen Smith is a professor of dermatology at the University of California, Irvine. Dr. Smith specializes in melanoma, skin cancer, the tongue and complex medical dermatology. She is also well known for her clinical and teaching skills and writes frequently for a number of Dermatology Journals. Dr Smith recently stepped down as President of the Pacific Dermatologic Association and continues on their Board of Directors.  She attended medical school at the University of Iowa and was trained in dermatology at the University of Michigan. She did an NIH fellowship at Washington University in St Louis where she was later on faculty. She has also been on faculty at the University of Minnesota and the University of California, San Francisco. Smith is a Fellow of the American Academy of Dermatology and board certified by the American Board of Dermatology. Smith’s past research includes melanoma and stem cell biology.

Professor Benjamin Zephaniah
Chair of Creative Writing Brunel University

Benjamin Zephaniah is probably one of the most high-profile international authors writing today, with an enormous breadth of appeal, equally popular with adults and children. Most well-known for his performance poetry with a political edge for adults and ground-breaking performance poetry for children, Benjamin has also written several novels for teenagers. Benjamin has his own rap/reggae band and has appeared on Desert Island Discs. He travels the world speaking about his books and poetry

Dr Alia Ahmed is a Consultant Dermatologist and Site Clinical Lead for Dermatology at Frimley Health Foundation Trust. She is also an Honorary Consultant at Barts Health NHS Trust. Dr Ahmed graduated from Barts and the Royal London School of Medicine in 2008 and completed her Dermatology training in London, including a research fellowship in Psychodermatology, becoming a consultant in 2017. She also has a BSc in Psychology with Clinical Psychology.
In addition to her NHS work, Dr Ahmed is an honorary lecturer in Psychodermatology at the University of Hertfordshire. She is active in research and has presented internationally, as well as having several peer-reviewed publications and a research fellowship with the UK Dermatology Clinical Trials Network. Dr Ahmed is on the executive committee for Psychodermatology UK, and a spokesperson for the British Skin Foundation, as well as a contributor to the All Party Parliamentary Group on Skin. She is a regular contributor to several periodicals and enjoys writing about the link between mind and skin.
Her specialist interest is in the psychological effects of chronic skin disease, specifically the link between the skin and stress. Dr Ahmed is part of the Psychodermatology team based at The Royal London Hospital, where she sees tertiary referrals. This clinic is specifically for people whose lives have been severely affected by their dermatological disease. Dr Ahmed provides holistic care to her patients, and strongly believes the interaction between the brain, skin and mind is key to achieving healthy skin.

Dr Ophelia E. Dadzie (FRCP, DipRCPath (Dermpath), MSc (Genomic Medicine) is a Consultant Dermatologist (The Hillingdon Hospitals NHS Foundation Trust) and Dermatopathologist (Clinical Lead for Dermatopathology, North West London Pathology Centre, Imperial College Healthcare NHS Trust). She has a long-standing interest in human cutaneous diversity. She has published original research work, as well as a textbook on this topic and lectures nationally and internationally on this topic. Dr Dadzie also holds her MSc in Genomic Medicine-her thesis was about the development of a novel pan-African SNP genotyping array- with particular emphasis on the diversity and complexity of the ‘African’ genome.

Dermatologist and Allergologist and Physician of Psychosomatic Medicine and Psychotherapy, Chair of Psychodermatology Dept. at Vitos Giessen and Prof. at Dept. of Dermatology, Univ. Giessen Germany and Head of Atopic Dermatitis School Academy Hessen. Prof. Gieler run many studies in the field of psychodermatology, is honorary president of the European Society of Dermatology and Psychiatry and Member of the German, French and Austrian Society of Dermatology and Venereology. He is author of more than 450 papers in the field of psychodermatology and a very first member of the European Academy of Dermatology and Venereology (EADV), he is also reviewer for the JEADV and other high impact journals in the fiel of dermatology reviewing many papers.

Dr Matthew Harries received his medical degree from the University of Leeds, UK (1998). In 2001, he gained membership in the Royal College of Physicians of London, and in January 2003 took a post as a Specialist Registrar in Dermatology in Manchester. During training he took time out of programme to study the hair immune system in primary cicatricial alopecias, working as a Clinical Research Fellow at the University of Manchester, and a visiting Research Fellow in Experimental Dermatology at the University of Lübeck, Germany. He was awarded a PhD from the University of Manchester in 2011. He now works as a Consultant Dermatologist at Salford Royal Foundation Trust in Greater Manchester, is an Honorary Senior Lecturer at the University of Manchester and a Fellow of the Royal College of Physicians in London. He has a special interest in hair loss disorders, in particular the scarring alopecias, receiving specialist referrals from around the region. He is the deputy lead of the NIHR Manchester BRC inflammatory hair loss research programme, research lead for the British Hair and Nails Society (BHNS), a member of the BSF large grant awards committee and also sits on the Alopecia UK charity research committee. He is currently leading the BAD alopecia areata clinical guidelines update and the acquired hair disorders chapter in the next Rook Textbook of Dermatology.

Kieron Leslie is a professor of dermatology at the University of California, San Francisco (UCSF). He graduated MB BS from St. Bartholomew’s and The Royal London School of Medicine in 1996, and completed his general medical training at the Royal Free  and University College hospitals in London. His dermatology training was initiated at the Middlesex Hospital and he was subsequently appointed specialist registrar at the Norfolk & Norwich University Hospital. He also graduated with the Diploma of Tropical Medicine & Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine. Taking a leap into the unknown and across the pond, he joined the faculty of UCSF in 2005. His research and clinical interests fall in to 2 separate areas. The first being autoinflammatory diseases where Professor Leslie helped to define the clinical phenotype of Cryopyrin Associated Periodic Syndrome (CAPS). He was part of the team that led to licensing of canakinumab (Ilaris) as a treatment for CAPS in both Europe and the USA. He has also studied the role of autoinflammatory in other skin conditions, such as hidradenitis suppurativa. His other interest is skin diseases as complications of HIV. He now directs the HIV Dermatology Clinic at San Francisco General Hospital. An expanding area of clinical care and research is Kaposi’s Sarcoma. He is extensively published in dermatology journals such as JAAD, JAMA Derm & BJD and also general medical journals such as the New England Journal of Medicine and the Journal of Experimental Medicine. He is a founder member of the Gay and Lesbian Association of Dermatology (GALDA) and an honorary member of the British Association of Dermatologists.

Nick Levell has been a consultant dermatologist in Norwich for over 25 years (except for a month as a consultant in older persons medicine during the Covid-19 crisis).  He is employed by the NHS GIRFT programme as national clinical lead in dermatology and also by the National Institute of Health Research as Speciality National Lead.  A past-President of the British Association of Dermatologists and the British Society of Medical Dermatology, he chairs the BAD Therapy and Guidelines Committee, is Vice-President of the European Society for the history of Dermatovenerology and BAD Willan librarian.  His research interests include health economics, epidemiology, health services research, medical history and clinical research in cellulitis and inflammatory skin diseases.

I am a GP in Bournemouth and a researcher at the University of Southampton. My research interest is in supporting people to manage their own long-term conditions, including eczema, and looking for strategies to reduce antimicrobial use, including in acne. In terms of research methods, I focus on pragmatic randomised controlled trials and qualitative research.

Professor Mini Singh is Professor of Medical Education and Honorary Consultant Dermatologist at the University of Manchester. She was awarded the prestigious Principal Fellow of the Higher Education Academy for her strategic leadership in both undergraduate and postgraduate healthcare education. She is Associate Director for Teaching and Learning for University of Manchester Medical School where she is responsible for curriculum development, design and implementation across the six-year programme. Her national work includes Chair of the Undergraduate Workstream for the British Association of Dermatology and committee membership of the UK Clinical Reasoning in Medical Education Group (UK CReME).  She has a keen interest in the science of clinical decision-making having delivered multiple talks and workshops on the topic both nationally and globally.

Dr. Victoria Werth is a Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania and Chief of the Division of Dermatology at the Philadelphia Veterans Administration Hospital. Dr. Werth earned her medical degree from Johns Hopkins University School of Medicine in Baltimore, Maryland. She completed a residency in internal medicine at Northwestern Memorial Hospital in Chicago, Illinois, and dermatology residency and immunodermatology fellowship at New York University School of Medicine in New York, funded by the NIH and Dermatology Foundation. She joined the faculty at Penn in 1989 and has developed an internationally recognized program in autoimmune skin diseases.

She is a co-founder of the Rheumatologic Dermatology Society and previous president of the group. She is co-founder of the Medical Dermatology Society, and a recipient of their lifetime achievement award. She initiated the combined internal medicine/dermatology residency program in the U.S., which has successfully trained prominent leaders in complex medical dermatology. She has a longstanding interest in clinical and translational research pertaining to autoimmune skin diseases, including cutaneous lupus erythematosus, dermatomyositis, and autoimmune blistering diseases, with a focus on improving the outcomes of autoimmune dermatologic diseases. She has developed and validated disease severity tools now used in many international trials for these diseases, with a goal to advancing evidence for current and new therapeutics. Her laboratory studies include studies in cutaneous lupus and dermatomyositis that relate to pathogenesis and heterogeneity of response to treatment, and ultraviolet light effects on skin. Recent clinical studies have examined mechanistic effects of therapeutics in CLE, as well as subset-specific expression of cytokine signatures. Her work has been funded by the Dermatology Foundation, NIH, DOD, the Veterans Administration, the Lupus Research Alliance, the Lupus Foundation of America, the Myositis Association, the International Pemphigus and Pemphigoid Foundation, CARRA, and industry.

Follow B.A.D on Twitter